Allergan Continues at Neutral
Drug Intervention in the News
Drug Intervention: Allergan Continues At Neutral
Moreover, in May 2011, Allergan entered into a licensing agreement with Molecular Partners AG and obtained global rights to MP0112, which is being investigated for the treatment of retinal diseases. We note that Allergan's lead drug, Botox, …
Read more on Daily Markets
Drug Intervention: Drug rehab project doing street interventions
By Stabroek staff | 0 Comments | Local | Wednesday, August 24, 2011 The Phoenix Recovery Project (PRP) recently launched a Street-Based Intervention programme that offers meals to drug addicts living on the streets while also providing first line …
Read more on Stabroek News
Find More Drug Intervention Information…
<BR%20/>Tags: drug intervention, retinal diseases, Allergan, Neutral, drug rehab <BR%20/>